Differences between domestic and imported Vancevir/Valganciclovir

Valganciclovir (Valganciclovir) is a drug used to treat cytomegalovirus (CMV) retinitis in patients with acquired immunodeficiency syndrome (AIDS) and to prevent CMV infection in high-risk solid organ transplant patients. There are differences between the domestic and imported versions in many aspects. However, according to current understanding, the original drug of valganciclovir (imported version) has been marketed and sold in China under the trade name of Vancevir, but its domestic generic version has not yet been marketed and sold in China, and it may be under clinical development.

If there is domestic valganciclovir on the market, the main ingredient of the drug and imported valganciclovir are the same, that is, valganciclovir, which means that the pharmacological effects and therapeutic effects of the two should be similar or the same. However, since pharmaceutical manufacturers may be different, there may be some differences in drug production processes, quality control, etc. Imported drugs often pass strict international certifications, such as those from the U.S. Food and Drug Administration (FDA). These certifications provide globally recognized quality assurance for imported drugs. When patients use imported drugs, they can be more assured of their efficacy and safety.

In addition, there may be differences in packaging and labeling between domestically produced and imported valganciclovir. Imported drugs usually have more detailed instructions and labels in English, while domestic drugs are mainly in Chinese. In terms of price, generally speaking, the price of domestic drugs is relatively low, while the price of imported drugs is relatively high. Common packaging is 10 tablets of 450mg and 60 tablets of 0.45g. Each box sells for about 10,000 yuan. Versions sold overseas include imported versions from Türkiye, India and Switzerland, priced at about 4,000 yuan in a 60-piece package (price fluctuates with exchange rates).